Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats

The aim of this study was to investigate the protective effects of telmisartan and/or pyridoxamine on spontaneously hypertensive rats (SHRs). Rats were treated with telmisartan (T group) or pyridoxamine (P group), or telmisartan and pyridoxamine (TP group). The serum levels of advanced glycation end...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular medicine reports 2012-03, Vol.5 (3), p.655-662
Hauptverfasser: Zhu, Pengli, Lin, Hong, Sun, Chengai, Lin, Fan, Yu, Huizhen, Zhuo, Xiuping, Zhou, Chanjuan, Deng, Zhisheng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 662
container_issue 3
container_start_page 655
container_title Molecular medicine reports
container_volume 5
creator Zhu, Pengli
Lin, Hong
Sun, Chengai
Lin, Fan
Yu, Huizhen
Zhuo, Xiuping
Zhou, Chanjuan
Deng, Zhisheng
description The aim of this study was to investigate the protective effects of telmisartan and/or pyridoxamine on spontaneously hypertensive rats (SHRs). Rats were treated with telmisartan (T group) or pyridoxamine (P group), or telmisartan and pyridoxamine (TP group). The serum levels of advanced glycation end products (AGEs), superoxide dismutase (SOD), malonaldehyde and the level of 24-h urinary albumin were measured. Morphological changes in renal tissues were observed under light (H&E or Masson's trichrome) and transmission electron microscopy. Expression of NF-κBp65 and p-ERK1/2 in renal tissue was detected by immunohistochemistry. Expression of receptors for advanced glycation end products (RAGE) and TGF-β in the renal cortex was investigated by western blotting. We found that early renal structural and functional damage was alleviated in the three intervention groups. SOD activity was significantly elevated in the P and TP groups (P
doi_str_mv 10.3892/mmr.2011.717
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2765347964</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2765347964</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-1e346d04ecf9c57521077677b8f2c3f71cdd1cc7fe550bb02bbe3cd3257f89413</originalsourceid><addsrcrecordid>eNo9kE1LxDAQhoMo7rp68ywBr3bNR9Nsj7L4BQse1HNIk8mapU1r0or993Zx9TQD87wvw4PQJSVLvirZbdPEJSOULiWVR2hOZUkzTkh-fNhZWcoZOktpR0ghmChP0YwxRohkco7q1zFA3PrUe4PBOTB9wq3DPdSNTzr2OmAdLO7G6G37rRsfALcBg471iCMEXWOrG70F7ANOXRumBLRDmq4fYwexh5D8F-Co-3SOTpyuE1wc5gK9P9y_rZ-yzcvj8_pukxkuij6jwPPCkhyMK42QglEiZSFltXLMcCepsZYaIx0IQaqKsKoCbixnQrpVmVO-QNe_vV1sPwdIvdq1Q5xeTYrJQvBclkU-UTe_lIltShGc6qJvdBwVJWqvVk1q1V6tmtRO-NWhdKgasP_wn0v-A_SIduQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2765347964</pqid></control><display><type>article</type><title>Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats</title><source>Spandidos Publications Journals</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Zhu, Pengli ; Lin, Hong ; Sun, Chengai ; Lin, Fan ; Yu, Huizhen ; Zhuo, Xiuping ; Zhou, Chanjuan ; Deng, Zhisheng</creator><creatorcontrib>Zhu, Pengli ; Lin, Hong ; Sun, Chengai ; Lin, Fan ; Yu, Huizhen ; Zhuo, Xiuping ; Zhou, Chanjuan ; Deng, Zhisheng</creatorcontrib><description>The aim of this study was to investigate the protective effects of telmisartan and/or pyridoxamine on spontaneously hypertensive rats (SHRs). Rats were treated with telmisartan (T group) or pyridoxamine (P group), or telmisartan and pyridoxamine (TP group). The serum levels of advanced glycation end products (AGEs), superoxide dismutase (SOD), malonaldehyde and the level of 24-h urinary albumin were measured. Morphological changes in renal tissues were observed under light (H&amp;E or Masson's trichrome) and transmission electron microscopy. Expression of NF-κBp65 and p-ERK1/2 in renal tissue was detected by immunohistochemistry. Expression of receptors for advanced glycation end products (RAGE) and TGF-β in the renal cortex was investigated by western blotting. We found that early renal structural and functional damage was alleviated in the three intervention groups. SOD activity was significantly elevated in the P and TP groups (P&lt;0.05) compared to that in the T group. Of note, both the positive expression of NF-κBp65 (P&lt;0.01 vs. the T and P groups) and p-ERK1/2 (P&lt;0.05 vs. the P group) was lowest in the TP group. Our results suggest that the combined use of telmisartan and pyridoxamine is superior to the single use of either drug on renoprotection, which may result from the alleviation of oxidative stress and the reduction of NF-κBp65 and p-ERK1/2 activation.</description><identifier>ISSN: 1791-2997</identifier><identifier>EISSN: 1791-3004</identifier><identifier>DOI: 10.3892/mmr.2011.717</identifier><identifier>PMID: 22200727</identifier><language>eng</language><publisher>Greece: Spandidos Publications UK Ltd</publisher><subject>Advanced glycosylation end products ; Animals ; Antibodies ; Antigens ; Benzimidazoles - pharmacology ; Benzoates - pharmacology ; Bioengineering ; Blood pressure ; Drug Synergism ; Endocrine system ; Gastric lavage ; Glycation End Products, Advanced - blood ; Glycosylation ; Hypertension ; Immunohistochemistry ; Kidney - drug effects ; Kidney - metabolism ; Kidney - pathology ; Laboratory animals ; Male ; Malondialdehyde ; Malondialdehyde - analysis ; Malondialdehyde - blood ; Medical research ; Mitogen-Activated Protein Kinase 1 - metabolism ; Mitogen-Activated Protein Kinase 3 - metabolism ; Oxidative stress ; Protective Agents - pharmacology ; Proteins ; Pyridoxamine - pharmacology ; Rats ; Rats, Inbred SHR ; Receptor for Advanced Glycation End Products ; Receptors, Immunologic - metabolism ; Renal cortex ; Serum levels ; Signal transduction ; Structure-function relationships ; Superoxide dismutase ; Superoxide Dismutase - blood ; Transcription Factor RelA - metabolism ; Transforming Growth Factor beta - metabolism ; Transmission electron microscopy ; Variance analysis ; Western blotting</subject><ispartof>Molecular medicine reports, 2012-03, Vol.5 (3), p.655-662</ispartof><rights>Copyright Spandidos Publications UK Ltd. 2012</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-1e346d04ecf9c57521077677b8f2c3f71cdd1cc7fe550bb02bbe3cd3257f89413</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22200727$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhu, Pengli</creatorcontrib><creatorcontrib>Lin, Hong</creatorcontrib><creatorcontrib>Sun, Chengai</creatorcontrib><creatorcontrib>Lin, Fan</creatorcontrib><creatorcontrib>Yu, Huizhen</creatorcontrib><creatorcontrib>Zhuo, Xiuping</creatorcontrib><creatorcontrib>Zhou, Chanjuan</creatorcontrib><creatorcontrib>Deng, Zhisheng</creatorcontrib><title>Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats</title><title>Molecular medicine reports</title><addtitle>Mol Med Rep</addtitle><description>The aim of this study was to investigate the protective effects of telmisartan and/or pyridoxamine on spontaneously hypertensive rats (SHRs). Rats were treated with telmisartan (T group) or pyridoxamine (P group), or telmisartan and pyridoxamine (TP group). The serum levels of advanced glycation end products (AGEs), superoxide dismutase (SOD), malonaldehyde and the level of 24-h urinary albumin were measured. Morphological changes in renal tissues were observed under light (H&amp;E or Masson's trichrome) and transmission electron microscopy. Expression of NF-κBp65 and p-ERK1/2 in renal tissue was detected by immunohistochemistry. Expression of receptors for advanced glycation end products (RAGE) and TGF-β in the renal cortex was investigated by western blotting. We found that early renal structural and functional damage was alleviated in the three intervention groups. SOD activity was significantly elevated in the P and TP groups (P&lt;0.05) compared to that in the T group. Of note, both the positive expression of NF-κBp65 (P&lt;0.01 vs. the T and P groups) and p-ERK1/2 (P&lt;0.05 vs. the P group) was lowest in the TP group. Our results suggest that the combined use of telmisartan and pyridoxamine is superior to the single use of either drug on renoprotection, which may result from the alleviation of oxidative stress and the reduction of NF-κBp65 and p-ERK1/2 activation.</description><subject>Advanced glycosylation end products</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Benzimidazoles - pharmacology</subject><subject>Benzoates - pharmacology</subject><subject>Bioengineering</subject><subject>Blood pressure</subject><subject>Drug Synergism</subject><subject>Endocrine system</subject><subject>Gastric lavage</subject><subject>Glycation End Products, Advanced - blood</subject><subject>Glycosylation</subject><subject>Hypertension</subject><subject>Immunohistochemistry</subject><subject>Kidney - drug effects</subject><subject>Kidney - metabolism</subject><subject>Kidney - pathology</subject><subject>Laboratory animals</subject><subject>Male</subject><subject>Malondialdehyde</subject><subject>Malondialdehyde - analysis</subject><subject>Malondialdehyde - blood</subject><subject>Medical research</subject><subject>Mitogen-Activated Protein Kinase 1 - metabolism</subject><subject>Mitogen-Activated Protein Kinase 3 - metabolism</subject><subject>Oxidative stress</subject><subject>Protective Agents - pharmacology</subject><subject>Proteins</subject><subject>Pyridoxamine - pharmacology</subject><subject>Rats</subject><subject>Rats, Inbred SHR</subject><subject>Receptor for Advanced Glycation End Products</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Renal cortex</subject><subject>Serum levels</subject><subject>Signal transduction</subject><subject>Structure-function relationships</subject><subject>Superoxide dismutase</subject><subject>Superoxide Dismutase - blood</subject><subject>Transcription Factor RelA - metabolism</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Transmission electron microscopy</subject><subject>Variance analysis</subject><subject>Western blotting</subject><issn>1791-2997</issn><issn>1791-3004</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNo9kE1LxDAQhoMo7rp68ywBr3bNR9Nsj7L4BQse1HNIk8mapU1r0or993Zx9TQD87wvw4PQJSVLvirZbdPEJSOULiWVR2hOZUkzTkh-fNhZWcoZOktpR0ghmChP0YwxRohkco7q1zFA3PrUe4PBOTB9wq3DPdSNTzr2OmAdLO7G6G37rRsfALcBg471iCMEXWOrG70F7ANOXRumBLRDmq4fYwexh5D8F-Co-3SOTpyuE1wc5gK9P9y_rZ-yzcvj8_pukxkuij6jwPPCkhyMK42QglEiZSFltXLMcCepsZYaIx0IQaqKsKoCbixnQrpVmVO-QNe_vV1sPwdIvdq1Q5xeTYrJQvBclkU-UTe_lIltShGc6qJvdBwVJWqvVk1q1V6tmtRO-NWhdKgasP_wn0v-A_SIduQ</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Zhu, Pengli</creator><creator>Lin, Hong</creator><creator>Sun, Chengai</creator><creator>Lin, Fan</creator><creator>Yu, Huizhen</creator><creator>Zhuo, Xiuping</creator><creator>Zhou, Chanjuan</creator><creator>Deng, Zhisheng</creator><general>Spandidos Publications UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20120301</creationdate><title>Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats</title><author>Zhu, Pengli ; Lin, Hong ; Sun, Chengai ; Lin, Fan ; Yu, Huizhen ; Zhuo, Xiuping ; Zhou, Chanjuan ; Deng, Zhisheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-1e346d04ecf9c57521077677b8f2c3f71cdd1cc7fe550bb02bbe3cd3257f89413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Advanced glycosylation end products</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Benzimidazoles - pharmacology</topic><topic>Benzoates - pharmacology</topic><topic>Bioengineering</topic><topic>Blood pressure</topic><topic>Drug Synergism</topic><topic>Endocrine system</topic><topic>Gastric lavage</topic><topic>Glycation End Products, Advanced - blood</topic><topic>Glycosylation</topic><topic>Hypertension</topic><topic>Immunohistochemistry</topic><topic>Kidney - drug effects</topic><topic>Kidney - metabolism</topic><topic>Kidney - pathology</topic><topic>Laboratory animals</topic><topic>Male</topic><topic>Malondialdehyde</topic><topic>Malondialdehyde - analysis</topic><topic>Malondialdehyde - blood</topic><topic>Medical research</topic><topic>Mitogen-Activated Protein Kinase 1 - metabolism</topic><topic>Mitogen-Activated Protein Kinase 3 - metabolism</topic><topic>Oxidative stress</topic><topic>Protective Agents - pharmacology</topic><topic>Proteins</topic><topic>Pyridoxamine - pharmacology</topic><topic>Rats</topic><topic>Rats, Inbred SHR</topic><topic>Receptor for Advanced Glycation End Products</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Renal cortex</topic><topic>Serum levels</topic><topic>Signal transduction</topic><topic>Structure-function relationships</topic><topic>Superoxide dismutase</topic><topic>Superoxide Dismutase - blood</topic><topic>Transcription Factor RelA - metabolism</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Transmission electron microscopy</topic><topic>Variance analysis</topic><topic>Western blotting</topic><toplevel>online_resources</toplevel><creatorcontrib>Zhu, Pengli</creatorcontrib><creatorcontrib>Lin, Hong</creatorcontrib><creatorcontrib>Sun, Chengai</creatorcontrib><creatorcontrib>Lin, Fan</creatorcontrib><creatorcontrib>Yu, Huizhen</creatorcontrib><creatorcontrib>Zhuo, Xiuping</creatorcontrib><creatorcontrib>Zhou, Chanjuan</creatorcontrib><creatorcontrib>Deng, Zhisheng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Molecular medicine reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhu, Pengli</au><au>Lin, Hong</au><au>Sun, Chengai</au><au>Lin, Fan</au><au>Yu, Huizhen</au><au>Zhuo, Xiuping</au><au>Zhou, Chanjuan</au><au>Deng, Zhisheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats</atitle><jtitle>Molecular medicine reports</jtitle><addtitle>Mol Med Rep</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>5</volume><issue>3</issue><spage>655</spage><epage>662</epage><pages>655-662</pages><issn>1791-2997</issn><eissn>1791-3004</eissn><abstract>The aim of this study was to investigate the protective effects of telmisartan and/or pyridoxamine on spontaneously hypertensive rats (SHRs). Rats were treated with telmisartan (T group) or pyridoxamine (P group), or telmisartan and pyridoxamine (TP group). The serum levels of advanced glycation end products (AGEs), superoxide dismutase (SOD), malonaldehyde and the level of 24-h urinary albumin were measured. Morphological changes in renal tissues were observed under light (H&amp;E or Masson's trichrome) and transmission electron microscopy. Expression of NF-κBp65 and p-ERK1/2 in renal tissue was detected by immunohistochemistry. Expression of receptors for advanced glycation end products (RAGE) and TGF-β in the renal cortex was investigated by western blotting. We found that early renal structural and functional damage was alleviated in the three intervention groups. SOD activity was significantly elevated in the P and TP groups (P&lt;0.05) compared to that in the T group. Of note, both the positive expression of NF-κBp65 (P&lt;0.01 vs. the T and P groups) and p-ERK1/2 (P&lt;0.05 vs. the P group) was lowest in the TP group. Our results suggest that the combined use of telmisartan and pyridoxamine is superior to the single use of either drug on renoprotection, which may result from the alleviation of oxidative stress and the reduction of NF-κBp65 and p-ERK1/2 activation.</abstract><cop>Greece</cop><pub>Spandidos Publications UK Ltd</pub><pmid>22200727</pmid><doi>10.3892/mmr.2011.717</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1791-2997
ispartof Molecular medicine reports, 2012-03, Vol.5 (3), p.655-662
issn 1791-2997
1791-3004
language eng
recordid cdi_proquest_journals_2765347964
source Spandidos Publications Journals; MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Advanced glycosylation end products
Animals
Antibodies
Antigens
Benzimidazoles - pharmacology
Benzoates - pharmacology
Bioengineering
Blood pressure
Drug Synergism
Endocrine system
Gastric lavage
Glycation End Products, Advanced - blood
Glycosylation
Hypertension
Immunohistochemistry
Kidney - drug effects
Kidney - metabolism
Kidney - pathology
Laboratory animals
Male
Malondialdehyde
Malondialdehyde - analysis
Malondialdehyde - blood
Medical research
Mitogen-Activated Protein Kinase 1 - metabolism
Mitogen-Activated Protein Kinase 3 - metabolism
Oxidative stress
Protective Agents - pharmacology
Proteins
Pyridoxamine - pharmacology
Rats
Rats, Inbred SHR
Receptor for Advanced Glycation End Products
Receptors, Immunologic - metabolism
Renal cortex
Serum levels
Signal transduction
Structure-function relationships
Superoxide dismutase
Superoxide Dismutase - blood
Transcription Factor RelA - metabolism
Transforming Growth Factor beta - metabolism
Transmission electron microscopy
Variance analysis
Western blotting
title Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T19%3A41%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synergistic%20effects%20of%20telmisartan%20and%20pyridoxamine%20on%20early%20renal%20damage%20in%20spontaneously%20hypertensive%20rats&rft.jtitle=Molecular%20medicine%20reports&rft.au=Zhu,%20Pengli&rft.date=2012-03-01&rft.volume=5&rft.issue=3&rft.spage=655&rft.epage=662&rft.pages=655-662&rft.issn=1791-2997&rft.eissn=1791-3004&rft_id=info:doi/10.3892/mmr.2011.717&rft_dat=%3Cproquest_cross%3E2765347964%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2765347964&rft_id=info:pmid/22200727&rfr_iscdi=true